Inventor · disambiguated record
Ronald P. Gladue
Also filed as: GLADUE RONALD P
15 granted patents·18 pending applications·929 citations·filing 2001–2021
95Inventor score
Top patents by PatentIndex Score
33 records- 0198US7338660B2Methods of treating cancer and enhancing immune responses with antibodies that bind CD40ABGENIX INC·Filed 2005·Granted Mar 4, 2008·144 cites·73 claims
- 0298US7288251B2Antibodies to CD40PFIZER·Filed 2002·Granted Oct 30, 2007·158 cites·22 claims
- 0397US7960515B2Binding molecules to the human OX40 receptorBRISTOL MYERS SQUIBB CO·Filed 2008·Granted Jun 14, 2011·205 cites·12 claims
- 0497US7626012B2Nucleic acid molecules which encode antibodies that bind CD40AMGEN FREMONT INC·Filed 2008·Granted Dec 1, 2009·53 cites·21 claims
- 0597US7618633B2Antibodies that bind CD40 and methods of treating cancer and enhancing immune responsesAMGEN FREMONT INC·Filed 2007·Granted Nov 17, 2009·63 cites·45 claims
- 0697US7563442B2Antibodies to CD40 and methods of treating cancer and enhancing immune responsesABGENIX INC·Filed 2005·Granted Jul 21, 2009·62 cites·133 claims
- 0796US8388971B2Antibodies that bind CD40 and methods of treating cancer and enhancing immune responsesBEDIAN VAHE·Filed 2012·Granted Mar 5, 2013·32 cites·20 claims
- 0896US8236930B2Binding molecules to the human OX40 receptorMIN JING·Filed 2011·Granted Aug 7, 2012·85 cites·5 claims
- 0995US9028824B2Binding molecules to the human OX40 receptorMIN JING·Filed 2012·Granted May 12, 2015·75 cites·22 claims
- 1088US8710191B2Antibodies to CCR2GLADUE RONALD P·Filed 2009·Granted Apr 29, 2014·21 cites·11 claims
- 1182US6649611B2Piperazine derivativesPFIZER·Filed 2001·Granted Nov 18, 2003·20 cites·6 claims
- 1278US10196452B2Binding molecules to the human OX40 receptorPFIZER·Filed 2017·Granted Feb 5, 2019·1 cites·16 claims
- 1376US2022002428A1Binding molecules to the human ox40 receptorPFIZER·Filed 2021·Application pending·0 cites
- 1470US9238691B2Nucleic acids encoding antibodies to CCR2PFIZER·Filed 2014·Granted Jan 19, 2016·1 cites·31 claims
- 1570US2010098694A1Antibodies to cd40AMGEN FREMONT INC·Filed 2009·Application pending·0 cites
- 1667US6878522B2Methods for the identification of compounds useful for the treatment of disease states mediated by prostaglandin D2Filed 2001·Granted Apr 12, 2005·9 cites·11 claims
- 1767US2005136055A1CD40 antibody formulation and methodsPFIZER·Filed 2004·Application pending·0 cites
- 1867US2009311254A1Cd40 antibody formulation and methodsPFIZER·Filed 2009·Application pending·0 cites
- 1967US2019135932A1Binding molecules to the human ox40 receptorPFIZER·Filed 2019·Application pending·0 cites
- 2062US2013024956A1Antibodies to cd40PFIZER·Filed 2012·Application pending·0 cites
- 2161US2012263732A1Cd40 antibody formulation and methodsGLADUE RONALD P·Filed 2012·Application pending·0 cites
- 2259US9840562B2Binding molecules to the human OX40 receptorPFIZER·Filed 2015·Granted Dec 12, 2017·0 cites·24 claims
- 2359US2016152713A1Antibodies to cd40AMGEN FREMONT INC·Filed 2015·Application pending·0 cites
- 2454US2011104182A1Cd40 antibody formulation and methodsPFIZER·Filed 2010·Application pending·0 cites
- 2553US2004087571A1Methods of using CCR1 antagonists as immunomodulatory agentsPFIZER·Filed 2003·Application pending·0 cites
- 2648US2004058932A1Novel piperazine derivativesPFIZER·Filed 2003·Application pending·0 cites
- 2746US2003232048A1Methods for treating chronic obstructive pulmonary disease (COPD)Filed 2003·Application pending·0 cites
- 2844US2004092529A1Methods of using piperazine derivativesPFIZER·Filed 2003·Application pending·0 cites
- 2944US2004097554A1Heteroaryl-hexanoic acid amide derivatives as immonomodulatory agentsPFIZER·Filed 2003·Application pending·0 cites
- 3044US2004116441A1Methods of using sulfonic acid derivativesPFIZER·Filed 2003·Application pending·0 cites
- 3140US2002168358A1Treatment of T-cell mediated diseasesFiled 2002·Application pending·0 cites
- 3240US2002119961A1Bridged piperazine derivativesPFIZER·Filed 2001·Application pending·0 cites
- 3339US2009196823A1Chemokine antagonists as treatment for obesity-related and metabolic syndrome-related conditionsPFIZER·Filed 2005·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →